Clinical Associate Professor Ben Miskle is a contributing author of a new national review examining pharmacist reimbursement policy, highlighting ongoing efforts to expand pharmacists' roles in patient care.

Published in the Journal of the American College of Clinical Pharmacy (JACCP), the report finds that states continue to make significant progress in recognizing and reimbursing pharmacists for clinical services. Since 2024, 16 states have enacted major legislative or regulatory changes expanding pharmacist reimbursement through commercial insurance, Medicaid, or both. These reforms include payment parity laws, expanded prescribing authority, Medicaid provider enrollment, and reimbursement for services such as test-and-treat programs, preventive care, and chronic disease management.

The authors conclude that while federal provider status legislation has progressed slowly, state-led efforts are steadily transforming pharmacy practice. Today, 43 states have some mechanism supporting payment for pharmacist-provided clinical services, although reimbursement models, covered services, and implementation vary considerably.

Iowa has emerged as one of the national leaders in this movement. Following passage of the Iowa Standards of Care Act in 2024, pharmacists across the state have expanded patient care services while health systems and community pharmacies have developed credentialing, billing, and practice models that support pharmacist-provided care. Faculty at the College have contributed through scholarship, advocacy, and collaboration with pharmacy leaders statewide.

The full article is available in JACCP.